Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Major Acquisitions Now A Necessary Part Of Pfizer's Future Strategy
Forbes
Tuesday, May 6, 2014 - 9:22am
tags:
Pfizer, M&A, AstraZeneca, Wyeth, R&D
Astra gets lift in Pfizer fight as U.S. okays heart pill
Reuters
Tuesday, May 6, 2014 - 9:11am
tags:
Pfizer, AstraZeneca, FDA, fish oil, Epanova
Pfizer’s Breakup Options Shift Even With AstraZeneca Bid
Bloomberg
Tuesday, May 6, 2014 - 9:10am
tags:
Pfizer, AstraZeneca, restructuring, M&A
Bayer to Buy Merck Consumer-Health Unit for $14.2 Billion
Bloomberg
Tuesday, May 6, 2014 - 9:09am
tags:
Bayer, Merck, consumer health, DTC, M&A
Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO
Fierce Biotech
Monday, May 5, 2014 - 5:15pm
tags:
IPOs, Bristol-Myers Squibb, Ambrx
Merck proposal to sell Singulair without a prescription hits resistance
Fierce Pharma
Monday, May 5, 2014 - 5:08pm
tags:
Merck, Singulair, OTC
Pfizer’s Pipeline: 2 Drugs That May Drive Future Revenues
Wall St Cheat Sheet
Monday, May 5, 2014 - 5:06pm
tags:
Pfizer, palbociclib, breast cancer, RN316
Acorda Down on Plumiaz CRL
Yahoo/Zacks.com
Monday, May 5, 2014 - 5:05pm
tags:
Acorda Therapeutics, Plumiaz, epilepsy
Paging the Doctor: Is There a Cure for Pfizer?
Wall St Cheat Sheet
Monday, May 5, 2014 - 5:03pm
tags:
Pfizer, earnings, AstraZeneca
Gilead Sciences - Sovaldi's Pricing In A New Perspective
Seeking Alpha
Monday, May 5, 2014 - 5:02pm
tags:
Gilead Sciences, Sovaldi, hepatitis C
Is Merrimack Pharmaceuticals Worth More Than $700 Million?
Motley Fool
Monday, May 5, 2014 - 5:02pm
tags:
Merrimack Pharmaceuticals, pancreatic cancer, MM-398, Gemzar, Eli Lilly, Celgene, Abraxane
Vivus Earnings On Tap
Seeking Alpha
Monday, May 5, 2014 - 4:59pm
tags:
earnings, Vivus
Celgene: Do The Revlimid Polymorph And Use Patents Matter?
Seeking Alpha
Monday, May 5, 2014 - 12:09pm
tags:
Celgene, Revlimid
Narrower-than-Expected Loss at Seattle Genetics
Yahoo/Zacks.com
Monday, May 5, 2014 - 11:44am
tags:
earnings, Seattle Genetics
Earnings Beat at Pharmacyclics, Guidance Pulls Down Stock
Yahoo/Zacks.com
Monday, May 5, 2014 - 11:32am
tags:
earnings, Pharmacyclics
Pfizer's 'weak' Q1 numbers bolster case for AZ buy--and post-merger split, too
Fierce Pharma
Monday, May 5, 2014 - 10:22am
tags:
earnings, M&A, Pfizer, AstraZeneca
Monday’s Top Health Care Stories: Pfizer, Auxilium, and Regeneron
Motley Fool
Monday, May 5, 2014 - 10:15am
tags:
Pfizer, Auxilium, Regeneron, earnings, Avalanche Biotechnologies
Clinical Trial Results Indicate Acthar May Significantly Reduce Disease Activity in Patients with Systemic Lupus Erythematosus
Yahoo
Monday, May 5, 2014 - 10:01am
tags:
SLE, H.P. Acthar Gel, Questcor Pharmaceuticals
Biotech: a More Encouraging Chart
Barron's
Monday, May 5, 2014 - 9:57am
tags:
biotech
Idenix's Q1 Loss Widens
Yahoo/Zacks.com
Monday, May 5, 2014 - 9:56am
tags:
earnings, Idenix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.